Sexual Health Education Grant is a grant from The MAC AIDS Fund (now ViiV Healthcare Positive Action) that funds community-led organizations committed to eliminating AIDS and supporting people living with HIV.

The Positive Action program offers two funding streams: Innovator Funding (up to £100,000 over two years) for piloting new approaches, and Momentum Funding (up to £300,000 over three years) for scaling proven, evidence-based interventions. Priority areas include reducing HIV-related stigma, supporting community health systems, and closing gaps in paediatric and adolescent HIV care.

Eligible applicants are nonprofits — particularly those supporting sexual health, HIV/AIDS, and community education, including U.S.-based organizations. Grant amounts range from ,000 to ,000. The application deadline is May 15, 2026.

You are now leaving our ViiV Healthcare website and being re-directed to an external website Adverse event reporting can be found at the bottom of the page We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS.

Visit the About us section Our commitment to global health Learn about our HIV medicines Information for healthcare professionals Whilst we continue to find new ways to treat, prevent, and ultimately find a cure for HIV, we are also focusing on understanding how we can bridge the gap between research and everyday clinical practice through implementation science and patient centred studies.

Learn about our HIV research Innovation in HIV science Clinical Trials and Studies HIV Implementation Science We work actively with communities affected by HIV and AIDS around the world. Read about our community engagement initiatives.

How we support the HIV community Positive Perspectives research We are the only pharmaceutical company solely focused on curing HIV and AIDS, but of course, none of what we do can be achieved alone – we believe in the power of partnership. We are ViiV Healthcare: 100% dedicated to HIV medicines and research and completely focused on people affected by HIV and AIDS.

Visit the About us section Our commitment to global health Learn about our HIV medicines Information for healthcare professionals Whilst we continue to find new ways to treat, prevent, and ultimately find a cure for HIV, we are also focusing on understanding how we can bridge the gap between research and everyday clinical practice through implementation science and patient centred studies.

Learn about our HIV research Innovation in HIV science Clinical Trials and Studies HIV Implementation Science We work actively with communities affected by HIV and AIDS around the world. Read about our community engagement initiatives.

How we support the HIV community Positive Perspectives research We are the only pharmaceutical company solely focused on curing HIV and AIDS, but of course, none of what we do can be achieved alone – we believe in the power of partnership.

Community Strategic Initiatives Case Studies: Closing gaps in paediatric and adolescent HIV Case Studies: Supporting community health systems Case Studies: Reducing HIV related stigma and discrimination Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV.

Through its Community Strategic Initiatives, Positive Action provides funding to community-led and community-based organisations that are committed to eliminating AIDS and supporting people living with HIV. We currently offer funding under two funding streams, Innovator Funding, that aims to test and pilot new ways of working, and Momentum Funding, that aims to scale-up proven ways of working.

Up to £100,000 over two years (£50,000 per year) Investments into the testing and piloting of new approaches The proposed approach(es) must be new to the funding applicant but can have been delivered by another organisation in a different location or aimed at a different target population.

A two 2- year pilot that aims to build evidence before scale-up Up to £300,000 over three years (£ 100,000 per year) Advancing existing, evidence-based projects to enable sustainable scale-up The funding applicant must have delivered the approach(es) previously and have evidence that the approach(es) work Funding can be used to build on previous investments made by Positive Action or other donors A three-year scale-up aimed at advancing previous projects with a focus on sustaining interventions beyond the three-year Positive Action investment We currently have no open funding rounds.

NP-GBL-HVX-COCO-220063 | November 2025 Reporting of side effects If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.

public. reportum. com/ .

By reporting side effects, you can help provide more information on the safety of this medicine. If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here . Our Clinical Trial Register Corporate ethics and compliance NP-GBL-HVX-COCO-230027 February 2026 You are about to leave a ViiV Healthcare website.

By clicking this link, you will be taken to a website that is independent from ViiV Healthcare. The site you are linking to is not controlled or endorsed by ViiV Healthcare and ViiV Healthcare is not responsible for the content provided on that site.

NP-GBL-HVX-COCO-220042 | November 2021 This is an archived press release which may not reflect current medical knowledge and should not be used as a source of information on the present label, safety data or efficacy data for ViiV Healthcare products and/or their uses. Please refer to your nationally approved label or summary of product characteristics for up-to-date product information.